Search for: "Endo Health Solutions Inc" Results 21 - 39 of 39
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Aug 2013, 5:58 am by Darren
Other Transvaginal Mesh Implant makers, including Johnson & Johnson (JNJ), Endo Health Solutions Inc. [read post]
20 Aug 2013, 9:43 am
Other companies facing significant transvaginal mesh litigation include Johnson & Johnson, Boston Scientific Corp. and Endo Health Solutions Inc. [read post]
24 Jul 2013, 11:12 pm
Meanwhile, according to Reuters, in June 2013, Endo Health Solutions, which owns American Medical Systems, Inc., agreed to pay more than $54.5 million to settle thousands of lawsuits in North America alleging its vaginal-mesh implants eroded and caused women pain. [read post]
18 Jul 2013, 9:52 pm by CSSFIRM.COM
Other Transvaginal Mesh Implant makers, including Johnson & Johnson (JNJ), Endo Health Solutions Inc. [read post]
26 Jun 2013, 8:30 am
American Medical System Inc., unit of Endo Health Solutions agreed to pay $54.5M to settle lawsuits of women who were in pain and left with incontinence after having transvaginal mesh surgically implanted. [read post]
26 Jun 2013, 7:30 am by The Borchardt Law Firm, PLLC
American Medical System Inc., unit of Endo Health Solutions agreed to pay $54.5M to settle lawsuits of women who were in pain and left with incontinence after having transvaginal mesh surgically implanted. [read post]
26 Jun 2013, 7:30 am by The Borchardt Law Firm, PLLC
American Medical System Inc., unit of Endo Health Solutions agreed to pay $54.5M to settle lawsuits of women who were in pain and left with incontinence after having transvaginal mesh surgically implanted. [read post]
26 Jun 2013, 7:30 am by The Borchardt Law Firm, PLLC
American Medical System Inc., unit of Endo Health Solutions agreed to pay $54.5M to settle lawsuits of women who were in pain and left with incontinence after having transvaginal mesh surgically implanted. [read post]
26 Jun 2013, 7:30 am by The Borchardt Law Firm, PLLC
American Medical System Inc., unit of Endo Health Solutions agreed to pay $54.5M to settle lawsuits of women who were in pain and left with incontinence after having transvaginal mesh surgically implanted. [read post]
24 Jun 2013, 9:10 am
An Endo Health Solutions Inc. unit has agreed that it will pay $54.5 million in order to settle lawsuits alleging that its vaginal-mesh implants eroded in some women, leaving them incontinent and in pain. [read post]
9 Aug 2012, 5:00 am by Bexis
(bowel preparation solution) Deposition2007-07-10 Pryor v. [read post]
5 Jun 2012, 11:35 am
Bard Inc. and Endo Health Solutions Inc., along with other manufacturers. [read post]
2 Mar 2012, 6:52 am by Bexis
(bowel preparation solution) Deposition2007-07-10 Pryor v. [read post]
28 Jun 2011, 5:03 pm
" Ethicon Endo-Surgery, Inc. v. [read post]
4 May 2011, 7:52 am by Tron Emptage
Misuse and abuse of narcotics represent three areas of particular concern for workers compensation insurers including:   Potential for serious health risks. [read post]
27 Apr 2010, 10:58 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: Kenya High Court suspends Anti-Counterfeiting Act ‘in as far as it applies to generic medicines’ (Afro-IP) (Michael Geist) India: Roche and Tarceva in Delhi HC again, this time vs Natco (Spicy IP) (Generic Pharmaceuticals and IP) Ecuador: Compulsory license granted to Cipla for Lopinavir + Ritonavir (Generic… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer (Spicy… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer (Spicy… [read post]